Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial. [electronic resource]
Producer: 20160219Description: 2305-14 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Antibodies, Bispecific -- administration & dosage
- Breast Neoplasms -- mortality
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Immunotherapy
- Interleukin-2 -- administration & dosage
- Kaplan-Meier Estimate
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.